Robert Wood Johnson University Hospital Somerset’s Community Health Department is offering a variety of free online community health education programs throughout September.
They include:
- Webinar: Mindful Eating: Are You Conscious of Your Consumption?, Wednesday, Sept. 16, 12 to 12:30 p.m. Amy Walsh, certified diabetes educator and manager of the Diabetes Education Center at Robert Wood Johnson University Hospital Somerset, will discuss strategies to improve your relationship with food and activity. Learn about the hospital’s new 10-week Mindfulness-Based Eating Awareness Program. To register, go to https://tinyurl.com/ycdh9vb3
- Webinar: The Prostate Paradigm, Thursday, Sept. 22, from 12 to 12:30 p.m. Dr. Dhiren Dave, a urologist and robotic surgeon at Robert Wood Johnson University Hospital Somerset, will discuss urological conditions such as incontinence, benign prostatic hyperplasia and prostate cancer. Learn about the risk factors, signs and causes for these conditions as well as diagnostic testing and surgical options, including the da Vinci Robotic Surgical System. To register, visit https://tinyurl.com/ycpn5e5c
- Webinar: Bouncing Back from Rejection: Build the Resilience You Need to Get Back Up When Life Knocks You Down, Wednesday, Sept. 23, 12 to 12:30 p.m. Leslie Becker-Phelps, PhD, psychologist and author of “Bouncing Back from Rejection,” will help you learn to cope better with rejection and bounce back after difficult experiences by developing confidence and awareness through five domains: Sensations, Thoughts, Emotions, Actions and Mentalizing (STEAM). You will learn how to relate to yourself and others in more positive ways, even when difficult situations arise. To register, visit https://tinyurl.com/y7t5rqs6
- Webinar: Facing Ovarian Cancer: A Woman’s Guide to Health, Wednesday, Sept. 30, 12 to 12:30 p.m. Learn more about ovarian cancer, including risk factors, symptoms, causes, diagnosis and treatments. Fertility preservation will also be discussed. To register, visit https://tinyurl.com/y7knegsk